Recro takes on big brother role with opioid addiction drug maker, handling manufacturing duties and advising on FDA work

Just three weeks ago, CDMO Recro Pharma expanded its footprint to the West Coast, as it acquired San Diego-based Irisys for $50 million cash. The …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Re­cro takes on big broth­er role with opi­oid ad­dic­tion drug mak­er, han­dling man­u­fac­tur­ing du­ties and ad­vis­ing on FDA work